Literature DB >> 20136911

Therapeutic Hotline: Recommendations on photoprotection and vitamin D.

Robert J Sage1, Henry W Lim.   

Abstract

Interest in the health benefits of vitamin D continues to increase and is at the forefront of much research and debate. Insufficient vitamin D levels have been linked in epidemiologic studies to decreased physical performance, cardiac health, autoimmune disease, neurologic disorders, colorectal and breast cancers, and total mortality. Consequently, health authorities are reviewing the most recent available data and updated recommendations on optimal vitamin D levels are pending. Daily intake of 1000 international units (IU) of vitamin D for adults and 400 IU of vitamin D for children may be appropriate for patients protecting their skin from UV radiation and can be safely obtained from diet and/or dietary supplementation. Patients should be counseled on sun protection regimens to prevent unprotected sun exposure and discouraged from using artificial tanning devices. As available information on vitamin D and its associated health benefits evolves, and as new evidence emerges, updated recommendations are sure to follow.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20136911     DOI: 10.1111/j.1529-8019.2009.01293.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  3 in total

Review 1.  A dermatologist's perspective on vitamin D.

Authors:  Veena Vanchinathan; Henry W Lim
Journal:  Mayo Clin Proc       Date:  2012-03-14       Impact factor: 7.616

Review 2.  Visible light. Part II: Photoprotection against visible and ultraviolet light.

Authors:  Amaris N Geisler; Evan Austin; Julie Nguyen; Iltefat Hamzavi; Jared Jagdeo; Henry W Lim
Journal:  J Am Acad Dermatol       Date:  2021-02-25       Impact factor: 11.527

3.  Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial.

Authors:  J De Smedt; S Van Kelst; V Boecxstaens; M Stas; K Bogaerts; D Vanderschueren; C Aura; K Vandenberghe; D Lambrechts; P Wolter; O Bechter; A Nikkels; T Strobbe; G Emri; V Marasigan; M Garmyn
Journal:  BMC Cancer       Date:  2017-08-23       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.